Leaders in Pharmaceutical Business Intelligence (LPBI) Group

More Awards to Jennifer Doudna: 2016 Warren Alpert Foundation Prize and The 2015 Pfizer Lecture

Reporter: Aviva Lev-Ari, PhD, RN

2.1.5.9   More Awards to Jennifer Doudna: 2016 Warren Alpert Foundation Prize and The 2015 Pfizer Lecture, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair

2015 Inaugural Pfizer Lecture with Jennifer Doudna, Ph.D.

Pfizer Cambridge presents the 2015 Inaugural Pfizer Lecture honoring Jennifer Doudna, Ph.D., innovator in the field of biomedical research, on Thursday, Sept. 10, 2015

September 10, 2015 | 3:30 p.m. EST

Refreshments at 4:45 p.m.

Kresge Auditorium, MIT Campus

Free | Open to public

Register: http://tinyurl.com/2015PfizerLecture

The 2015 Pfizer Lecture will be given by Jennifer Doudna, Ph.D., University of California, Berkeley Professor and Howard Hughes Medical Institute Investigator. Dr. Doudna is recognized for her innovative accomplishments in biomedical research, including work on the biochemical characterization of the revolutionary CRISPR-Cas9 gene editing system that is transforming biology and medicine research around the world.

The annual Pfizer Lectureship event brings together the Massachusetts life sciences community to explore noteworthy research, celebrate innovation and facilitate new connections among the broader Boston/Cambridge biomedical community. Central to the Lectureship Event is the recognition of an individual, external to Pfizer, whose scientific contributions have helped accelerate the pace of innovation.

LIVE – The CRISPR/Cas9 Revolution and Gene Editing: 2016 WARREN ALPERT FOUNDATION PRIZE SYMPOSIUM

Prize recipient:

Jennifer Doudna, PhD
Li Ka Shing Chancellor’s Chair in Biomedical and Health Sciences/HHMI Investigator
University of California, Berkeley
The Future of Genome Engineering: Biology, Technology and Ethics